Cancer Research UK logo.
SearchDonate
  • Search

A trial of pembrolizumab before surgery and with radiotherapy for head and neck cancer (KEYNOTE 689)

Overview

Cancer types:

Head and neck cancers, Laryngeal cancer, Mouth and oropharyngeal cancer, Pharyngeal cancer, Secondary cancers

Status:

Closed

Phase:

Phase 3

Details

This trial is for people with stage 3 or stage 4a of the:

  • mouth and oropharynx

  • larynx

15800 KEYNOTE-689 - Trial Diagram.

Stage 3 or stage 4a means one of the following:

  • the cancer is bigger than 4cm but has not spread into any lymph nodes or any other part of the body

  • the cancer is any size but has spread to one lymph node on the same side of the neck as the cancer. And the lymph node is no more than 3cm across

  • the cancer has grown through the tissues around the lips and mouth

Everyone taking part is going to have treatment for head and neck cancer for the first time.

Recruitment start: 10 January 2019

Recruitment end: 22 September 2023

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Dr Mary Lei

Supported by

Merck Sharp & Dohme Ltd

Last reviewed: 15 Nov 2023

CRUK internal database number: 15800

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.